Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans. The company expects the updated shot to be available, pending approval from health regulators in the United States, Europe and elsewhere, in the coming weeks for the fall vaccination season. Moderna and other COVID-19 vaccine makers Novavax, Pfizer and German partner BioNTec have created versions of their shots aimed at the XBB.1.5 subvariant.

http://klse.i3investor.com/web/blog/detail/kianweiaritcles/2023-08-18-story-h-242076579-Moderna_s_updated_COVID_vaccine_effective_against_Eris_variant_in_human

#i3investor